Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42DK048529-02
Application #
2016855
Study Section
Special Emphasis Panel (ZRG3-SSS-2 (01))
Project Start
1994-09-30
Project End
1998-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Mountain View Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025

  Publications

Hershfield, Michael S (2009) Reassessing serum urate targets in the management of refractory gout: can you go too low? Curr Opin Rheumatol 21:138-42
Kelly, S J; Delnomdedieu, M; Oliverio, M I et al. (2001) Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase. J Am Soc Nephrol 12:1001-9